SCOPUS 정보 검색 플랫폼

Volumn 31, Issue 21, 2013, Pages 2750-2751

Reply to S. Girnius et al

(14) Palladini, Giovanni a Dispenzieri, Angela b Gertz, Morie A b Kumar, Shaji b Wechalekar, Ashutosh c Hawkins, Philip N c Schönland, Stefan d Hegenbart, Ute d Comenzo, Raymond e Kastritis, Efstathios f Dimopoulos, Meletios A f Jaccard, Arnaud g Klersy, Catherine h Merlini, Giampaolo a

a UNIVERSITY OF PAVIA (Italy)

b MAYO CLINIC (United States)

c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL (United Kingdom)

d UNIVERSITY OF HEIDELBERG (Germany)

e TUFTS MEDICAL CENTER (United States)

f UNIVERSITY OF ATHENS MEDICAL SCHOOL (Greece)

g UNIVERSITY OF LIMOGES (France)

h C MONDINO NATIONAL NEUROLOGICAL INSTITUTE (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN;

AMYLOIDOSIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER SURVIVAL; HEART FAILURE; HUMAN; LETTER; MEDICAL SOCIETY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT RESPONSE;

AMYLOIDOSIS; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE;

EID: 84890538800 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2013.49.2512 Document Type: Letter

Times cited : (1)

References (4)

1
- 84890501484
- New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation
- Girnius S, Seldin DC, Cibeira MT, et al: New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation. J Clin Oncol 31:2749-2750, 2013
- (2013) J Clin Oncol , vol.31 , pp. 2749-2750
- Girnius, S.¹ Seldin, D.C.² Cibeira, M.T.³

2
- 84871772553
- New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: Impact on survival outcomes
- Palladini G, Dispenzieri A, Gertz MA, et al: New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: Impact on survival outcomes. J Clin Oncol 30:4541-4549, 2012
- (2012) J Clin Oncol , vol.30 , pp. 4541-4549
- Palladini, G.¹ Dispenzieri, A.² Gertz, M.A.³

3
- 80054844341
- Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: Long-term results in a series of 421 patients
- Cibeira MT, Sanchorawala V, Seldin DC, et al: Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: Long-term results in a series of 421 patients. Blood 118:4346-4352, 2011
- (2011) Blood , vol.118 , pp. 4346-4352
- Cibeira, M.T.¹ Sanchorawala, V.² Seldin, D.C.³

4
- 78149291059
- The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis
- Palladini G, Barassi A, Klersy C, et al: The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis. Blood 116:3426-3430, 2010
- (2010) Blood , vol.116 , pp. 3426-3430
- Palladini, G.¹ Barassi, A.² Klersy, C.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.